Literature DB >> 11029543

Serotonin uptake and release mechanisms in developing cultures of rat embryonic raphe neurons: age- and region-specific differences.

M Lautenschlager1, M Höltje, B von Jagow, R W Veh, C Harms, A Bergk, U Dirnagl, G Ahnert-Hilger, H Hörtnagl.   

Abstract

The development of serotonergic neurons of the rat raphe was followed in primary neuronal cell cultures taken at embryonic days embryonic day 13 and embryonic day 14 from three different raphe sub-groups, topographically defined with respect to their position to the isthmus as rostral (R1), intermediate (R2) and caudal (R3). In neurons cultivated from embryonic day 13 raphe serotonin, immunoreactivity was detected after only two days in vitro in the rostral R1 and the intermediate R2 sub-groups. Within two weeks of cultivation the number of serotonergic neurons as well as the dendritic branching continuously increased in all three sub-groups. In cultures obtained from embryonic day 13 raphe a specific uptake of [3H]serotonin could not be detected during the first days in vitro. Specific uptake as well as regulated serotonin release, however, was clearly discernible in these cultures after nine days in vitro, indicating developmental differentiation of the initially immature serotonergic neurons in culture. In contrast, serotonergic neurons obtained from the three raphe sub-groups at embryonic day 14 took up and released [3H]serotonin, as early as after two days in culture. Basal as well as stimulated serotonin release was diminished when preincubating the cells with tetanus toxin, which cleaves synaptobrevin thereby blocking exocytosis. Our data indicate that the differential development of serotonergic neurons in the various raphe sub-groups in vivo is also sustained in culture. The differences observed when comparing neurons from embryonic days 13 and 14 suggest that a short time-period of about 24h appears to be crucial for the developmental upregulation of serotonin uptake, storage and release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029543     DOI: 10.1016/s0306-4522(00)00222-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Direct inhibition of retinoic acid catabolism by fluoxetine.

Authors:  Julian Hellmann-Regen; Ria Uhlemann; Francesca Regen; Isabella Heuser; Christian Otte; Matthias Endres; Karen Gertz; Golo Kronenberg
Journal:  J Neural Transm (Vienna)       Date:  2015-05-17       Impact factor: 3.575

2.  Serotonin-induced down-regulation of cell surface serotonin transporter.

Authors:  Trine Nygaard Jørgensen; Peter Møller Christensen; Ulrik Gether
Journal:  Neurochem Int       Date:  2014-01-22       Impact factor: 3.921

3.  Morphological and physiological properties of serotonergic neurons in dissociated cultures from the postnatal rat dorsal raphe nucleus.

Authors:  Junko Yasufuku-Takano; Shigehiro Nakajima; Yasuko Nakajima
Journal:  J Neurosci Methods       Date:  2007-08-30       Impact factor: 2.390

4.  Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice.

Authors:  Valérie Boujon; Ria Uhlemann; Stephanie Wegner; Matthew B Wright; Ulrich Laufs; Matthias Endres; Golo Kronenberg; Karen Gertz
Journal:  J Mol Med (Berl)       Date:  2019-05-30       Impact factor: 4.599

5.  N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism.

Authors:  Keiko Iwata; Hideo Matsuzaki; Taro Tachibana; Koji Ohno; Saori Yoshimura; Hironori Takamura; Kohei Yamada; Shinsuke Matsuzaki; Kazuhiko Nakamura; Kenji J Tsuchiya; Kaori Matsumoto; Masatsugu Tsujii; Toshirou Sugiyama; Taiichi Katayama; Norio Mori
Journal:  Mol Autism       Date:  2014-05-10       Impact factor: 7.509

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.